Advertisement Management and Analysis of Biomarker Data - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


Management and Analysis of Biomarker Data

There is great expectation in the Pharmaceutical Industry that the era of personalised medicine will deliver safer and more effective treatments (Jørgensen & Winther, 2009). This promise is made possible by the emergence of new technologies and data acquisition platforms that can generate enormous amounts of patient-level biomarker data to characterise biological processes and explain response to treatment.